wire - news in brief
« BACK
Health - Social Sciences - 15:01 
Swiss TPH Awarded Four New Research Grants in Paediatric Health
Swiss TPH has been awarded four out of six new research grants from the Principal Investigator Initiative of the Botnar Research Centre for Child Health (BRCCH).
Innovation - Health - 17.05.2022 
Swiss Science celebrates Hansjörg Wyss
Successful research does not happen in a vacuum - it needs a lot of money and resources. In addition to governmental funding, generous donors are of central importance for the Swiss research ecosystem.
Health - 11.05.2022
Health - Innovation - 11.05.2022 
Exoskeleton device helps stroke victims regain hand function
Working closely with users and therapists, EPFL spin-off Emovo Care has developed a light and easy-to-attach hand exoskeleton for people unable to grasp objects following a stroke or accident.
Health - Environment - 03.05.2022
Health - Pharmacology - 29.04.2022
Health - Social Sciences - 28.04.2022 
Tackling the Consequences of Long Covid
A research team at the University of Zurich has helped people affected by Long Covid identify the problems they most urgently want scientists to tackle, through a collaborative citizen science approach. The topics identified as most pressing include the development and clinical testing of effective therapies, appropriate healthcare structures, increased awareness as well as better data on children and adolescents affected by the disease.
Life Sciences - Health - 26.04.2022
Health - 11.04.2022
Health - Environment - 01.04.2022
Health - 28.03.2022
Health - Innovation - 24.03.2022
Politics - Health - 23.03.2022
Health - 21.03.2022
Health - Pharmacology - 21.03.2022
Health - Physics - 21.03.2022 
Nontoxic, variable-stiffness threads for dexterous cardiac catheters
Engineers at EPFL and ETH developed a variable stiffness catheter made of nontoxic threads that can transition between soft and rigid states during surgery.
Health - Social Sciences - 16.03.2022 
Increasing Awareness of Noma - A Severe but Treatable Disease
There is very limited data on the incidence and prevalence of noma, which hinders better management and treatment of this devastating disease that mainly affects young and malnourished children in very poor communities.
Health - Environment - 10.03.2022
Health - Pharmacology - 07.03.2022 
Overcoming resistance to breast cancer treatment
A team from the UNIGE has identified a potential target for restoring the efficacy of standard treatment in resistant patients. Many breast cancer patients develop resistance to standard drug treatments aimed at preventing the growth of cancer cells. A team from the University of Geneva has identified a molecular regulator involved in these resistance mechanisms.
Health - Life Sciences - 03.03.2022 
Studying the human body to drive scientific progress
Human biology is the research focus of a number of EPFL labs, where scientists conduct clinical trials with volunteers to design therapeutic interventions and to learn more about how the body functions.
Life Sciences - Health - 03.03.2022
Health - Pharmacology - 28.02.2022 
Therapy for muscular dystrophy: A new start-up at the Biozentrum
Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up SEAL Therapeutics AG together with Dr. Thomas Meier, former CEO of Santhera Pharmaceuticals.
Health - 28.02.2022
Health - Life Sciences - 24.02.2022 
GliaPharm SA and the Wyss Center enter collaboration to develop new therapies for Alzheimer’s disease
The collaboration will accelerate the testing of GliaPharm's lead molecules in preclinical models of Alzheimer's disease and further the development of neuroimaging biomarkers Geneva, Switzerland - G
Health - 23.02.2022
Health - Pharmacology - 21.02.2022
Health - 17.02.2022
Pharmacology - Health - 16.02.2022
Health - 15.02.2022
Health - Pharmacology - 14.02.2022
Health - Pharmacology - 10.02.2022 
ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.
Health - Life Sciences - 10.02.2022
Health - Life Sciences - 07.02.2022
Health - Life Sciences - 04.02.2022
Health - Pharmacology - 02.02.2022
Health - Economics / Business - 31.01.2022 
Software that orchestrates secure and compliant data collaborations
As businesses grow increasingly reliant on data to make strategic decisions, more and more companies and organizations decide to collaborate and share information with each other.
Health - Pharmacology - 27.01.2022 
Omicron unlikely to push health system to limits
Seemingly less hazardous than Delta, but significantly more infectious: The spread of the omicron variant of the SARS-CoV-2 coronavirus raises the question of whether it can push the healthcare system to its breaking point. researchers have worked with partners to model scenarios for both Switzerland and Germany - and conclude that this is an unlikely course of events.
Life Sciences - Health - 27.01.2022
Health - Pharmacology - 26.01.2022
Health - Physics - 24.01.2022 
New rapid test could detect coronavirus and flu simultaneously
Researchers from the University of Basel and the Paul Scherrer Institute PSI have developed a rapid test for Covid-19 with a novel functional principle.
Life Sciences - Health - 24.01.2022 
’We generate tiny brains in the Petri dish’
Professor Verdon Taylor from the Department of Biomedicine at the University of Basel studies the development of the brain from stem cells, including using animal-free methods. Here, he explains which research questions can be answered using this approach - and why animal experiments are still needed.
Health - 24.01.2022
Life Sciences - Health - 17.01.2022 
Bearing the animal in mind
At the University of Basel, a large team of experts looks after the welfare of animals used in experiments. The aim is to minimize the stress placed on the animals. This is achieved by means of species-appropriate animal husbandry, careful planning of experiments and close monitoring of each animal.
Health - Life Sciences - 10.01.2022 
’We think carefully about how many mice are necessary’
Professor Alfred Zippelius, from the Department of Biomedicine at the University of Basel, has been conducting experiments with mice for several years.
Health - Campus - 06.01.2022
Health - Environment - 05.01.2022 
Better use of office daylighting can improve people's well-being
A PhD candidate at EPFL studied the use of automated control systems for blinds and electric lighting to regulate the amount of daylight in an office, and found that such systems can cut a building's energy demand and stimulate occupants' circadian rhythms, improving their health and well-being.
Health - Pharmacology - 24.12.2021
Health - Life Sciences - 22.12.2021
Health - Psychology - 21.12.2021 
Psychological stress and stress factors in vaccinated and unvaccinated people
The latest survey in the University of Basel's Swiss Corona Stress Study shows that psychological stress remains high during the pandemic.
Health
Results 1 - 50 of 2463.
Swiss TPH has been awarded four out of six new research grants from the Principal Investigator Initiative of the Botnar Research Centre for Child Health (BRCCH).
Successful research does not happen in a vacuum - it needs a lot of money and resources. In addition to governmental funding, generous donors are of central importance for the Swiss research ecosystem.
Working closely with users and therapists, EPFL spin-off Emovo Care has developed a light and easy-to-attach hand exoskeleton for people unable to grasp objects following a stroke or accident.
Three Simple Interventions for Cancer Prevention in Older People
A combination of high-dose vitamin D, omega-3 fatty acids and a simple home strength exercise program (SHEP) can cumulatively reduce the risk of cancer in healthy adults over the age of 70 by 61 percent, the international DO-HEALTH study led by the University of Zurich has shown. It is the first study to test the combined benefit of three affordable public health interventions for the prevention of invasive cancers.
A combination of high-dose vitamin D, omega-3 fatty acids and a simple home strength exercise program (SHEP) can cumulatively reduce the risk of cancer in healthy adults over the age of 70 by 61 percent, the international DO-HEALTH study led by the University of Zurich has shown. It is the first study to test the combined benefit of three affordable public health interventions for the prevention of invasive cancers.
A research team at the University of Zurich has helped people affected by Long Covid identify the problems they most urgently want scientists to tackle, through a collaborative citizen science approach. The topics identified as most pressing include the development and clinical testing of effective therapies, appropriate healthcare structures, increased awareness as well as better data on children and adolescents affected by the disease.
AI enables personalized treatment of heart muscle inflammation
A research team from the University of Bern and Inselspital, University Hospital Bern is investigating and developing innovative approaches that will enable personalized diagnosis and treatment of myocarditis.
A research team from the University of Bern and Inselspital, University Hospital Bern is investigating and developing innovative approaches that will enable personalized diagnosis and treatment of myocarditis.
A novel painless and reliable allergy test
Although allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear.
Although allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear.
Engineers at EPFL and ETH developed a variable stiffness catheter made of nontoxic threads that can transition between soft and rigid states during surgery.
There is very limited data on the incidence and prevalence of noma, which hinders better management and treatment of this devastating disease that mainly affects young and malnourished children in very poor communities.
Extreme temperatures come at a high price
A study prepared at the University of Bern shows in detail for the first time how heat in Switzerland has increasingly led to high death rates over the past 50 years.
A study prepared at the University of Bern shows in detail for the first time how heat in Switzerland has increasingly led to high death rates over the past 50 years.
A team from the UNIGE has identified a potential target for restoring the efficacy of standard treatment in resistant patients. Many breast cancer patients develop resistance to standard drug treatments aimed at preventing the growth of cancer cells. A team from the University of Geneva has identified a molecular regulator involved in these resistance mechanisms.
Human biology is the research focus of a number of EPFL labs, where scientists conduct clinical trials with volunteers to design therapeutic interventions and to learn more about how the body functions.
Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up SEAL Therapeutics AG together with Dr. Thomas Meier, former CEO of Santhera Pharmaceuticals.
The collaboration will accelerate the testing of GliaPharm's lead molecules in preclinical models of Alzheimer's disease and further the development of neuroimaging biomarkers Geneva, Switzerland - G
Patients Share Their Experiences
What do people with multiple sclerosis, dementia or chronic pain go through? What are their experiences of medical practices or hospitals like? What kind of support do they find helpful? The new dipe
What do people with multiple sclerosis, dementia or chronic pain go through? What are their experiences of medical practices or hospitals like? What kind of support do they find helpful? The new dipe
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.
New implant offers promise for the paralyzed
A system developed by Grégoire Courtine and Jocelyne Bloch now enables patients with a complete spinal cord injury to stand, walk and even perform recreational activities like swimming, cycling and canoeing. The images made headlines around the world in late 2018. David Mzee, who had been left paralyzed by a partial spinal cord injury suffered in a sports accident, got up from his wheelchair and began to walk with the help of a walker.
A system developed by Grégoire Courtine and Jocelyne Bloch now enables patients with a complete spinal cord injury to stand, walk and even perform recreational activities like swimming, cycling and canoeing. The images made headlines around the world in late 2018. David Mzee, who had been left paralyzed by a partial spinal cord injury suffered in a sports accident, got up from his wheelchair and began to walk with the help of a walker.
Spotlight on FMIers: Gisèle Ferrand
To discover the molecular mechanisms of health and disease, some FMI researchers use animals such as mice and fish.
To discover the molecular mechanisms of health and disease, some FMI researchers use animals such as mice and fish.
As businesses grow increasingly reliant on data to make strategic decisions, more and more companies and organizations decide to collaborate and share information with each other.
Seemingly less hazardous than Delta, but significantly more infectious: The spread of the omicron variant of the SARS-CoV-2 coronavirus raises the question of whether it can push the healthcare system to its breaking point. researchers have worked with partners to model scenarios for both Switzerland and Germany - and conclude that this is an unlikely course of events.
Researchers from the University of Basel and the Paul Scherrer Institute PSI have developed a rapid test for Covid-19 with a novel functional principle.
Professor Verdon Taylor from the Department of Biomedicine at the University of Basel studies the development of the brain from stem cells, including using animal-free methods. Here, he explains which research questions can be answered using this approach - and why animal experiments are still needed.
At the University of Basel, a large team of experts looks after the welfare of animals used in experiments. The aim is to minimize the stress placed on the animals. This is achieved by means of species-appropriate animal husbandry, careful planning of experiments and close monitoring of each animal.
Professor Alfred Zippelius, from the Department of Biomedicine at the University of Basel, has been conducting experiments with mice for several years.
A PhD candidate at EPFL studied the use of automated control systems for blinds and electric lighting to regulate the amount of daylight in an office, and found that such systems can cut a building's energy demand and stimulate occupants' circadian rhythms, improving their health and well-being.
The battle of the SARS-CoV-2 variants: a winning approach
In order to fight the pandemic in the long term, it is crucial to understand why one variant prevails over another. An international study conducted by the Institute of Virology and Immunology and the University of Bern, in collaboration with the Friedrich-Loeffler-Institut in Germany, has provided important answers by comparing the spread and transmission of different emerging variants in parallel.
In order to fight the pandemic in the long term, it is crucial to understand why one variant prevails over another. An international study conducted by the Institute of Virology and Immunology and the University of Bern, in collaboration with the Friedrich-Loeffler-Institut in Germany, has provided important answers by comparing the spread and transmission of different emerging variants in parallel.
The latest survey in the University of Basel's Swiss Corona Stress Study shows that psychological stress remains high during the pandemic.
